Exemed Pharmaceuticals, Phase – 4

R&D & ADL Facility Development: Civil construction for Exemed Pharmaceuticals—25,000+ sq. ft. facility (₹2.0 Cr), currently in progress from April 2026.

End-to-End Civil Scope: Execution includes R&D and ADL buildings along with all associated and allied works, ensuring quality and functional research infrastructure.